You have 9 free searches left this month | for more free features.

bicalutamide

Showing 1 - 25 of 108

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Breast Tumor Female, Breast Cancer, Breast Carcinoma Trial in Portland (Nivolumab, Ipilimumab, Bicalutamide)

Recruiting
  • Breast Neoplasm Female
  • +3 more
  • New York, New York
  • +1 more
Dec 21, 2022

Metastatic Breast Cancer (MBC) Trial in United States (Palbociclib, Bicalutamide)

Active, not recruiting
  • Metastatic Breast Cancer (MBC)
  • Basking Ridge, New Jersey
  • +4 more
Oct 31, 2022

Non-Muscle Invasive Bladder Cancer Trial in Québec (Bicalutamide, Control Arm)

Recruiting
  • Non-Muscle Invasive Bladder Cancer
  • Bicalutamide
  • Control Arm
  • Québec, Canada
    CHU de Québec-Université Laval
Jul 13, 2022

Triple Negative Breast Cancer Trial in United States (ribociclib, Bicalutamide)

Recruiting
  • Triple Negative Breast Cancer
  • Chicago, Illinois
  • +5 more
Oct 31, 2022

Breast Cancer Trial in United States (bicalutamide, diagnostic laboratory biomarker analysis, immunohistochemistry staining

Completed
  • Breast Cancer
  • bicalutamide
  • +2 more
  • San Francisco, California
  • +7 more
Jul 8, 2022

Prostate Adenocarcinoma Trial run by the (bicalutamide, Stereotactic body radiation therapy)

Recruiting
  • Prostate Adenocarcinoma
  • bicalutamide
  • Stereotactic body radiation therapy
  • Bethesda, Maryland
    National Cancer Institute
Oct 1, 2021

Breast Cancer, Metastasis Trial in New York (Abemaciclib, Bicalutamide)

Recruiting
  • Breast Cancer
  • Metastasis
  • New York, New York
  • +2 more
Oct 14, 2021

Prostate Cancer Trial in Madison (Docetaxel, Degarelix, Bicalutamide)

Completed
  • Prostate Cancer
  • Madison, Wisconsin
    University of Wisconsin Carbone Cancer Center
Sep 12, 2022

Prostate Cancer Trial in Washington, Baltimore (drug, procedure, radiation)

Completed
  • Prostate Cancer
  • Leuprolide Acetate
  • +4 more
  • Washington, District of Columbia
  • +2 more
Jul 11, 2022

Prostate Cancer Trial in Washington, Baltimore (Leuprolide Acetate, Docetaxel, Bicalutamide)

Active, not recruiting
  • Prostate Cancer
  • Leuprolide Acetate
  • +4 more
  • Washington, District of Columbia
  • +1 more
Mar 29, 2022

Prostate Cancer Trial in United States (Bicalutamide, GnRH Agonist, Radiation Therapy)

Recruiting
  • Prostate Cancer
  • Bicalutamide
  • +3 more
  • Stamford, Connecticut
  • +4 more
May 12, 2022

Adenocarcinoma of the Prostate, Recurrent Prostate Cancer, Stage IV Prostate Cancer Trial in Birmingham, Detroit, Columbus

Active, not recruiting
  • Adenocarcinoma of the Prostate
  • +2 more
  • Birmingham, Alabama
  • +3 more
Mar 2, 2021

Salivary Gland Tumors Trial in Shanghai (Pyrotinib, Bicalutamide, Leuprorelin)

Recruiting
  • Salivary Gland Neoplasms
  • Shanghai, Shanghai, China
    Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Ton
Oct 8, 2021

Prostate Cancer Trial in Chicago (Bicalutamide, Dutasteride, Finasteride)

Active, not recruiting
  • Prostate Cancer
  • Bicalutamide
  • +3 more
  • Chicago, Illinois
    University of Chicago
Sep 30, 2021

PSA Level Greater Than Two, Stage IV Prostate Adenocarcinoma AJCC v7 Trial in Duarte, South Pasadena (drug, radiation, other)

Active, not recruiting
  • PSA Level Greater Than Two
  • Stage IV Prostate Adenocarcinoma AJCC v7
  • Bicalutamide
  • +4 more
  • Duarte, California
  • +1 more
Apr 4, 2022

Prostate Adenocarcinoma, Stage I Prostate Cancer, Stage IIA Prostate Cancer Trial in Stanford (radiation, drug, other)

Active, not recruiting
  • Prostate Adenocarcinoma
  • +4 more
  • Internal Radiation Therapy
  • +7 more
  • Stanford, California
    Stanford University, School of Medicine
Feb 1, 2022

Castration-Sensitive Prostate Carcinoma, Metastatic Prostate Adenocarcinoma, Stage IV Prostate Cancer AJCC v8 Trial in Duarte

Recruiting
  • Castration-Sensitive Prostate Carcinoma
  • +4 more
  • Abiraterone Acetate
  • +7 more
  • Duarte, California
    City of Hope Medical Center
Oct 7, 2022

Prostate Adenocarcinoma, Recurrent Prostate Carcinoma Trial in Houston (Abiraterone Acetate, Bicalutamide, Degarelix)

Active, not recruiting
  • Prostate Adenocarcinoma
  • Recurrent Prostate Carcinoma
  • Abiraterone Acetate
  • +7 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 5, 2022

Prostate Cancer Trial in United States (GnRH, Bicalutamide, Salvage radiation)

Active, not recruiting
  • Prostate Cancer
  • San Diego, California
  • +7 more
Mar 7, 2022

Prostate Cancer Trial in France (drug, procedure, radiation)

Completed
  • Prostate Cancer
  • bicalutamide
  • +6 more
  • Angers, France
  • +37 more
Jan 17, 2023

Prostate Cancer, Bone Metastases, Prostate Tumors Trial in United States (LHRH agonist/antagonist, Bicalutamide, Radium-223

Terminated
  • Prostate Cancer
  • +2 more
  • LHRH agonist/antagonist
  • +2 more
  • Phoenix, Arizona
  • +11 more
Jul 7, 2022

High-risk Prostate Cancer, Prostate Cancer Trial in Houston (drug, radiation, procedure)

Recruiting
  • High-risk Prostate Cancer
  • Prostate Cancer
  • Houston, Texas
    Houston Methodist Hospital
Apr 5, 2021

Prostate Cancer Trial in Toronto (drug, procedure, radiation)

Completed
  • Prostate Cancer
  • bicalutamide
  • +4 more
  • Toronto, Ontario, Canada
    Toronto Sunnybrook Regional Cancer Centre
Oct 21, 2020

Breast Cancer Trial in Groningen (Bicalutamide, FDHT PET)

Completed
  • Breast Cancer
  • Bicalutamide
  • FDHT PET
  • Groningen, Netherlands
    University Medical Center Groningen
Nov 26, 2019

Prostate Cancer Trial in Canada, United States (bicalutamide, radiation therapy, )

Completed
  • Prostate Cancer
  • bicalutamide
  • +2 more
  • Birmingham, Alabama
  • +239 more
May 23, 2022